Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-12-18

Clinical Trial Update: Safety of Preoperative Oral Administration of a High Caloric Drink With Protein [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the safety of a preoperative high-calorie protein drink for postoperative nausea and vomiting has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital Muenster | Conditions: Postoperative Nausea and Vomiting | Phase 4 | Status: WITHDRAWN